分析患者的情况,以预测严重喘患者对支气管热塑术的反应
Satoshi Ano1, Norihiro Kikuchi2, Masashi Matsuyama3
1Department of Respiratory Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan; Department of Respiratory Medicine, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, Tsuchiura, Ibaraki 300-8585, Japan.
Respiratory investigation
|September 14, 2023
概括
预测患者对严重喘支气管热塑术 (BT) 的反应是具有挑战性的. 本综述检查了最近的奥米克和遗传数据,以确定BT疗效的预测因素.
科学领域:
- 肺病学和呼吸系统医学
- 生物标志物和奥米克研究研究
背景情况:
- 支气管热塑 (BT) 是一种独特的非药物治疗严重喘的方法.
- 目前的指导方针表达了谨慎,因为无法预测患者的反应.
- 现有的审查缺乏对响应预测指标的详细评估.
研究的目的:
- 审查最近发表的关于在严重喘中分析患者对BT反应的出版物.
- 解决关于BT疗效预测指标的文献缺口.
- 探索omics数据和遗传关联在预测BT结果中的作用.
主要方法:
- 系统审查最近的科学文献.
- 对专注于omics数据 (基因组学,转录组学等) 的研究进行分析. ) 的情况.
- 评估与BT反应相关的遗传关联.
主要成果:
- 在严重喘患者中预测BT的最佳反应仍然是一个重大的临床挑战.
- 缺乏可靠的预测标志物限制了BT的最后一线处理.
- 新兴研究强调了基因分析在预测BT疗效方面的潜力.
结论:
- 对患者概况的进一步研究对于优化BT治疗至关重要.
- 奥米克数据和遗传关联为预测BT反应提供了有希望的途径.
- 开发可靠的预测标记可以扩大BT在严重喘管理中的应用.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
295
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
295
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
241
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
241


